MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517025529 A) filed by Bridge Medicines, New York, on March 20, for 'inhibitors of enl/af9 yeats and flt3.'
Inventor(s) include Ladduwahetty, Tammy; Degorce, Sebastien, L.; and Vacca, Joseph, P.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "Compounds and pharmaceutical compositions comprising compounds that inhibit ENL/AF9 YEATS and FLT3 are disclosed herein. Methods for suppressing oncogene expression in a cell, or for treating acute leukemias, using the compounds and pharmaceutical compositions comprising the compounds are also disclosed. The compounds, pharmaceutical compositions and methods can be used to inhibit key drivers of cancer and cancer stem cell survival."
The patent application was internationally filed on Aug. 18, 2023, under International application No.PCT/US2023/072515.
Disclaimer: Curated by HT Syndication.
